Canadians will pay more for drugs under EU trade deal, researchers warn

The recently announced free-trade deal with Europe will likely cost Canadians hundreds of millions of dollars more for prescription drugs, says a new analysis.

The report, by two York University professors, says concessions by the federal government to cement the deal will delay the arrival cheap generic drugs by about a year, on average.

And the delay will add between $850 million and $1.65 billion — or up to 13 per cent — to the total drug bill paid annually by Canadians, either directly, through insurance plans or by provinces.

Read the source article at SmartBrief

About the Author

Leave a Reply